Abstract
With increased demand for smallpox vaccination during the nineteenth century, vaccination days—early mass vaccination campaigns—were conducted over time-limited periods to rapidly and efficiently protect maximum numbers of susceptible persons. Two centuries later, the challenge to rapidly and efficiently protect populations by mass vaccintion continues, despite the strengthening of routine immunization services in many countries through the Expanded Programme on Immunization strategies and GAVI support. Perhaps the most widely accepted reason for mass vaccination is to rapidly increase population (herd) immunity in the setting of an existing or potential outbreak, thereby limiting the morbidity and mortality that might result, especially when there has been no routine vaccination, or because populations have been displaced and routine immunization services disrupted. A second important use of mass vaccination is to accelerate disease control to rapidly increase coverage with a new vaccine at the time of its introduction into routine immunization programmes, and to attain the herd immunity levels required to meet international targets for eradication and mortality reduction. In the twenty-first century, mass vaccination and routine immunization remain a necessary alliance for attaining both national and international goals in the control of vaccine preventable disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hopkins DR (1983) Princes and peasants: Smallpox in history. University of Chicago Press, Chicago
Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, Geneva p 263
McLeod RM (1967) Law, Medicine and public opinion: the resistance to compulsory health legislation 1870–1907. Public Law 1967:6: 107–128, 189–211
Edwards EJ (1902) A concise history of small-pox and vaccination in Europe. London, Lewis
World Health Organization, 1966. World Health Assembly 19.16
Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, Geneva, pp 296–309
Fenner F, Henderson DA, Arita I, Jezêk X, Ladnyi ID (1988) Developments in Vaccination and Control: Smallpox and its Eradication. World Health Organization, Geneva, p 175
Fenner F, Henderson DA, Arita I, Jezêk X, LadnyiI D (1988) Developments in Vaccination and Control: Smallpox and its Eradication. World Health Organization, Geneva, p 1363–1365
Barrett S, Hoel M (2003) Optimal disease eradication. Frisch Centre, University of Oslo 203 (HERO working paper 23/2003)
Sencer JD, Axnick NW (1973) Cost benefit analysis. Immunological Standardization 22:37–46
Gonzalez CL (1965) Mass campaigns and general health services. World Health Organization, Geneva. Public Health Papers, no. 29
Mills A (2005) Mass campaigns versus general health services: what we have learnt in 40 years about vertical versus horizontal approaches. Bull World Health Org 83(4): 315–316
Henderson RH, Keja K, Galazka AM, Chan CA (1990) Reaping the benefits: getting vaccines to those who need them. In: Woodrow GC, Levine MM (eds). New Generation vaccines. Marcel Dekker, New York, pp 69–82
Henderson RH, Keja J, Hayden G, et al. (1988) Immunizing children of the world: progress and prospects. Bull World Health Org 66:535–543
Keegan R, Bilous J (2004) Current issues in global immunizations. Seminars in Pediatric Infectious Diseases. Elsevier, Amsterdam
Muraskin W (2004) The global alliance for vaccines and immunization: is it a new model for effective public-private cooperation in international public health? Am J Public Health 94:11:1922–1925
World Health Organization. “First, do no harm”. Introducing auto-disable syringes and ensuring injection safety in immunization systems of developing countries. WHO/V&B/02.26
Greenwood BM (1987) The epidemiology of acute bacterial meningitis in tropical Africa. In: Williams JD, Brunie J (eds). Bacterial meningitis. Academic Press, London, pp 61–91
Reingold AL, Broome CV, Hightower A, et al. (1985) Age specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 2:112–118
Schwartz B, Moore PS, Broome CV (1989) Global epidemiology of meningococcal disease. Clin Microbiol Rev 2:S118–S124
World Health Organization. Control of Epidemic meningococcal disease. WHO practical guidelines: second edition:WHO/EMC/BAC/98.3
Stohr K (2004) Influenza. In: Heymann DL (ed). Control of communicable diseases manual 18th edition, an official report of the American Public Health Association
Heymann DL (2005) Preparing for a New Global Threat—Part I. YaleGlobal, 26 January 2005. http://yaleglobal.yale.edu/display.article?id=5174
World Health Organization, 2000. Yellow Fever. WHO/EPI/GEN/98.11, WHO/CDS/EDC/2000.2
Connolly MA, Gayer M, Ryan MJ, Salama P, Spiegel P, Heymann DL (2004) Communicable Diseases in Complex Emergencies-impacts and challenges. Lancet 364:1974–83
World Health Organization (2004) Public health response to biological and chemical weapons, second edition
Heymann DL (2004) Smallpox containment updated: considerations for the 21st century. Int J Infect Dis 8(S2):S15–S20 (ISSN 1201-9712)
World Health Organization. Control of rubella and congenital rubella syndrome in developing countries. WHO/V&B/00.03
World Health Organization. Yellow Fever. WHO/EPI/GEN/98.11, WHO/CDS/EDC/2000.2
Heymann DL, Aylward RB (2004) Perspective article. Global Health: Eradicating Polio. New Engl J Med 351(13):1275–1277
Melgaard B, Creese A, Aylward B, Olivé J-M, Maher C, Okwo-Bele J-M, Lee JW (1998) Disease eradication and health systems development. Bull World Health Org (Suppl 2): 28–31
Dowdle WR (1998) The principles of disease elimination and eradication. Bull World Health Org (Suppl 2): 22–25
Bielik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers RN, Ngcobo N, Nxumalo M, Shearley A, Mabuzane E, Kufa E, Okwo-Bele J-M (2002). First 5 years of measles elimination in southern Africa: 1996–2000. Lancet 359(9137):1564–1568
World Health Organization. Field manual for neonatal tetanus elimination. WHO/V&B/99.14
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Heymann, D.L., Aylward, R.B. (2006). Mass Vaccination: When and Why. In: Plotkin, S.A. (eds) Mass Vaccination: Global Aspects — Progress and Obstacles. Current Topics in Microbiology and Immunology, vol 304. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-36583-4_1
Download citation
DOI: https://doi.org/10.1007/3-540-36583-4_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29382-8
Online ISBN: 978-3-540-36583-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)